Clinical application of a wearable integrated volitional control electrical stimulation device for patient with motor disability in upper extremity at subacute phase.

Mikami Yasuo0 sites30 target enrollmentFebruary 12, 2019

Overview

Phase: Phase 3
Intervention: Not specified
Conditions: Stroke, Traumatic brain injury, spinal cord injury, peripheral nerve injury
Sponsor: Mikami Yasuo
Enrollment: 30
Status: Recruiting
Last Updated: 2 years ago

No summary available.

Registry

who.int

Start Date

February 12, 2019

End Date

TBD

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

Mikami Yasuo

•Inclusion criteria is as following: 1\) the patient with motor disability in upper extremity, 2\)Those who passed within 180 days since onset, 3\) It is possible to detect the electromyogram of finger extension using the integrated volitional control electrical stimulation device.

•Exclusion criteria is as following: 1\) severe limited range of motion in wrist (wrist dorsiflexion\<0 degree), 2\) severe sensory disturbance (loss of superficial or deep sense), 3\) severe higher brain dysfunction (Mini\-mental state examination 23 points or less), 4\) patient who already treated with combination therapy such as transcranial magnetic stimulation, Botulinum toxin therapy, constraint induced movement therapy, or rehabilitation robot, 5\) patients with the contraindication of electrical stimulation therapy (Cardiovascular disease, Inserting a metal into the body like a pace maker, Infection, malignant tumor, use of metal implants for upper extremity, Abnormal blood pressure, Parts of abnormal skin, acute disease, Blood flow disturbance, pregnant woman)